-
Mashup Score: 0
Researchers have found an association between total national health expenditures and survival in patients with lymphoid malignancies.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Fuzuloparib, with or without apatinib, improved PFS over chemotherapy in patients with previously treated, HER2-negative, BRCA-mutated breast cancer.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Real-world data support the use of crizotinib as standard care for patients with advanced NSCLC with ROS1 fusions, according to researchers.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Identifying EGFR-Mutant Lung Cancer Patients Who Will Benefit From Immune Checkpoint Inhibitors - 4 day(s) ago
Real-world data suggest that lung cancer patients with uncommon EGFR mutations may benefit from treatment with immune checkpoint inhibitors.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0What to Do When NIPT Results Suggest Cancer - 5 day(s) ago
Studies have suggested that 0.002% to 0.03% of NIPT results may indicate a possible maternal cancer. Among patients with malignancy-suspicious NIPT results, 6.4% to 73.0% are diagnosed with a confirmed cancer. Experts have released recommendations for managing pregnant patients who have NIPT results suggesting they may have cancer.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Targeted Therapy Provides Greatest OS Benefit if Started Within 1 Month of NSCLC Diagnosis - 6 day(s) ago
A new study suggests that starting a patient on preferred targeted therapy within 1 year of metastatic non-small cell lung cancer diagnosis can still improve overall survival, when compared to other first-line therapies.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2How to Prevent and Prepare for Cyberattacks - 7 day(s) ago
The time to think about handling a cyberattack is not during an attack, according to Joyce Oh, vice president and chief information officer at Moffitt Cancer Center. Cyberattacks against health systems are becoming more common, but health care providers can take steps to prevent cyberattacks or stop them from derailing patient care.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
HRR testing is underused in patients with metastatic castration-resistant prostate cancer, a large study suggests.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Black adolescent and young adult cancer survivors may be less likely than their peers of other races and ethnicities to have a live birth after cancer, data suggest.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Another study adds to research suggesting that assisted reproductive technology may increase the risk of leukemia in offspring.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
Patients with #lymphoidMalignancies had a lower relative excess risk of death at 10 years if they lived in countries with the highest total national health expenditures. From @TheLancetOncol. https://t.co/22ORWIXiDl #lymsm #mmsm